Search for: "Hoffmann-La Roche" Results 1 - 20 of 181
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2019, 5:07 am
Hoffmann-La Roche AG ("Roche"), the owner of the [read post]
4 Jun 2018, 5:00 am by D Daniel Sokol
Mario Todino and Niccolò Colombo have written on Case C-179/16 Hoffmann-La Roche: By Object Restrictions Still Bitter Pills to Swallow? [read post]
10 May 2019, 8:45 am by D Daniel Sokol
Sophie Lawrance, Noel Watson-Doig, Edwin Bond, and Matthew Hunt describe Coty, Hoffmann-La Roche II, EAEPC, Commission SEP Communication and others: A Survey of Developments at the Intersection between Competition Law and IP Law in the Past Year. [read post]
31 Jul 2018, 11:45 am by D Daniel Sokol
Sophie Lawrance, Edwin Bond and Matthew Hunt recap AKKA/LAA, Coty, Hoffmann La Roche II and Others: A Survey of Cases at the Intersection between Competition Law and IP Law in the Past Year. [read post]
14 Apr 2009, 11:58 pm
Hoffmann-La Roche filed the lawsuit April 8, 2009 in the U.S. [read post]
27 Sep 2009, 9:59 pm
Hoffmann-La Roche's pegylated EPO analog, Mircera ® (see Amgen Inc. v. [read post]
5 Aug 2019, 4:06 pm
Hoffmann-La Roche AG and another [2019] EWHC 1520 (Pat) (20 June 2019) An "Arrow declaration" is a declaration that a product or process was known or obvious at a particular date and therefore could not fall within the claims of a [read post]
14 Jun 2011, 9:24 pm by Patent Docs
Hoffmann-La Roche Inc. v. [read post]
27 Jan 2013, 8:57 pm by Patent Docs
Hoffmann-La Roche Inc. et al. v. [read post]
30 Sep 2008, 3:00 am
Mint has further reported that Justice Abhay Oka of Mumbai High Court has asked Cipla to reply in two weeks to the patent infringement suit filed by Swiss-major F Hoffmann-La-Roche over anti-infection drug Valganciclovir. [read post]
11 Oct 2008, 4:45 am
Hoffmann-La Roche Ltd., Amgen's patent infringement suit over Roche's Mircera ® drug product. [read post]
14 Oct 2008, 4:55 am
Hoffmann-La Roche Ltd. , Amgen's patent infringement suit over Roche's Mircera ® drug product (see "Victory for Amgen in District Court Decision - Part I"). [read post]
10 Apr 2017, 3:47 am by Law Offices of Jeffrey S. Glassman
The drug was originally developed by Hoffmann-La Roche labs and was used to treat a severe skin condition known as nodular acne. [read post]